Table 3.
history of gestational diabetes | any diabetes during pregnancy | ever breastfed | >6 months breastfeeding | |||||
---|---|---|---|---|---|---|---|---|
beta | 95% CI | beta | 95% CI | beta | 95% CI | beta | 95% CI | |
1-carboxyethylisoleucinea, b | 0.1937 | −0.0161, 0.4036 | 0.2950 | 0.0801, 0.5098 | −0.1729 | −0.3160, −0.0297 | −0.2722 | −0.4648, −0.0795 |
1-carboxyethylleucinea, b | 0.2909 | 0.0732, 0.5085 | 0.3253 | 0.1111, 0.5395 | −0.1425 | −0.2858, 0.0008 | −0.2636 | −0.4562, −0.0710 |
2,3-dihydroxy-2-methylbutyratea,b | 0.0452 | −0.2094, 0.2997 | 0.0521 | −0.1866, 0.2908 | −0.0872 | −0.2463, 0.0718 | −0.1522 | −0.3664, 0.0621 |
2-hydroxy-3-methylvaleratea | 0.0469 | −0.1711, 0.2648 | 0.0414 | −0.1626, 0.2453 | −0.1713 | −0.3067, −0.0360 | −0.2189 | −0.4014, −0.0364 |
3-hydroxyisobutyratea | 0.1672 | −0.0872, 0.4215 | 0.1363 | −0.1035, 0.3761 | 0.1532 | −0.0063, 0.3126 | −0.0305 | −0.2460, 0.1851 |
3-methyl-2-oxovalerate | 0.2312 | −0.0050, 0.4675 | 0.2691 | 0.0454, 0.4927 | −0.0337 | −0.1834, 0.1160 | −0.1005 | −0.3022, 0.1013 |
3-methylglutaconatea | 0.2794 | 0.0159, 0.5429 | 0.1902 | −0.0565, 0.4368 | 0.0047 | −0.1599, 0.1694 | 0.0110 | −0.2110, 0.2392 |
3-methylglutarylcarnitine (2)a | 0.0952 | −0.1403, 0.3307 | 0.0157 | −0.2052, 0.2366 | −0.0164 | −0.1638, 0.1309 | 0.0523 | −0.1462, 0.2507 |
4-methyl-2-oxopentanoate | 0.1955 | −0.0442, 0.4351 | 0.2406 | 0.0139, 0.4674 | 0.0300 | −0.1217, 0.1816 | 0.0298 | −0.1747,0. 2342 |
alpha-hydroxyisovaleratea | 0.0807 | −0.1667, 0.3282 | 0.0575 | −0.1738, 0.2887 | −0.1645 | −0.3182, −0.0108 | −0.1948 | −0.4021, 0.0124 |
beta-hydroxyisovaleratea | −0.0643 | −0.3187, 0.1902 | −0.0544 | −0.2924, 0.1836 | −0.1169 | −0.2754, 0.0416 | −0.1132 | −0.3271, 0.1007 |
ethylmalonatea | −0.0326 | −0.2881, 0.2229 | −0.0162 | −0.2574, 0.2249 | 0.1317 | −0.0289, 0.2921 | 0.0659 | −0.1516, 0.28214 |
isobutyrylcarnitine (C4)a | −0.0278 | −0.2966, 0.2410 | −0.0586 | −0.3099, 0.1927 | −0.0820 | −0.2495, 0.0856 | −0.1097 | −0.3354, 0.1160 |
isobutyrylglycinea | 0.0219 | −0.2406, 0.2843 | 0.0138 | −0.2323, 0.2598 | −0.0775 | −0.2415, 0.0864 | −0.0040 | −0.2251, 0.2170 |
isovalerate (i5:0) | 0.0815 | −0.1816, 0.3447 | 0.0868 | −0.1596, 0.3332 | 0.0466 | −0.1175, 0.2107 | 0.0125 | −0.2088, 0.2338 |
isovalerylglycinea, b | 0.1434 | −0.1237, 0.4104 | 0.2068 | −0.0427, 0.4562 | −0.0613 | −0.2279, 0.1054 | −0.1619 | −0.3862, 0.0624 |
methylsuccinatea | 0.0228 | −0.2347, 0.2830 | 0.0503 | −0.1952, 0.2959 | 0.0964 | −0.0670, 0.2599 | −0.0272 | −0.2476, 0.1933 |
N-acetylisoleucinea | 0.1762 | −0.0768, 0.4292 | 0.1582 | −0.0784, 0.3948 | −0.1330 | −0.2906, 0.0247 | −0.1398 | −0.3505, 0.0746 |
N-acetylleucinea | 0.2466 | −0.0061, 0.4992 | 0.2020 | −0.0341, 0.4382 | −0.1779 | −0.3350, −0.0207 | −0.1534 | −0.3658, 0.0590 |
tiglylcarnitine (C5:1-DC) | 0.1173 | −0.1314, 0.3660 | 0.0534 | −0.1803, 0.2871 | 0.0989 | −0.0568, 0.2546 | 0.1268 | −0.0832, 0.3368 |
3-methyl-2-oxobutyrate | 0.0598 | −0.1805, 0.3002 | 0.1019 | −0.1242, 0.3279 | 0.0283 | −0.1225, 0.1791 | −0.0524 | −0.2557, 0.1509 |
isovalerylcarnitine (C5) | −0.0795 | −0.3414, 0.1822 | −0.1049 | −0.3497, 0.1399 | 0.0375 | −0.1275, 0.2009 | −0.0673 | −0.2877, 0.1529 |
2-methylbutyrylcarnitine (C5) | −0.0272 | −0.2692, 0.2148 | −0.0316 | −0.2623, 0.1900 | 0.0033 | −0.1475, 0.1541 | −0.0899 | −0.2931, 0.1132 |
1-carboxyethylvalinea, b | 0.2827 | 0.0733, 0.4931 | 0.3512 | 0.1401, 0.5624 | −0.1753 | −0.3165, −0.0340 | −0.2792 | −0.4692, −0.0892 |
3-hydroxy-2-ethylpropionate | 0.2767 | 0.0394, 0.5140 | 0.3308 | 0.1080, 0.5536 | 0.1779 | 0.0291, 0.3266 | 0.0936 | −0.1079, 0.2951 |
alpha-hydroxyisocaproatea,b | 0.2343 | 0.0027, 0.4660 | 0.2146 | −0.0054, 0.4347 | −0.1242 | −0.2710, 0.0226 | −0.3044 | −0.5012, −0.1075 |
N-carbamoylvalinea, b | 0.0254 | −0.2278, 0.2786 | 0.0629 | −0.1751, 0.3008 | 0.0757 | −0.0829, 0.2344 | 0.0631 | −0.1508, 0.2769 |
All results adjusted for age, BMI and waist circumference at time of metabolite measurement, average prior adult BMI, race, and menopausal status.
log-transformed to address skewness
>10% below the limit of detection; imputed as ½ LOD; results in supplementary material with values below LOD omitted